NCT00663767View on ClinicalTrials.gov

A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 7, 2008

Primary Completion Date

June 20, 2008

Study Completion Date

June 20, 2008

Conditions
Dental Pain
Interventions
DRUG

Placebo; oral

dose 1, dose 2

DRUG

Placebo; oral

dose 1

DRUG

ARRY-371797, p38 inhibitor; oral

dose 1: multiple dose levels

DRUG

ARRY-371797, p38 inhibitor; oral

dose 1: multiple dose levels; dose 2

DRUG

Celecoxib, COX-2 inhibitor; oral

dose 1

DRUG

Placebo; oral

dose 2

DRUG

ARRY-371797, p38 inhibitor; oral

dose 2

Trial Locations (2)

78744

PPD Phase I Clinic, Austin

84106

Lifetree Clinical Research, Salt Lake City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00663767 - A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction | Biotech Hunter | Biotech Hunter